OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Cancer Research and Clinical Oncology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Estimating the global burden of Epstein–Barr virus-related cancers	107
Role of lung and gut microbiota on lung cancer pathogenesis	101
Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patients	72
Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study	70
Gut microbiota-derived metabolites in CRC progression and causation	61
Cannabinoids in the landscape of cancer	60
Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters	56
Predictive biomarkers in gastric cancer	53
Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis	49
Cancer patients’ perspective on shared decision-making and decision aids in oncology	49
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer	47
Current trends of targeted therapy for oral squamous cell carcinoma	46
3D tumor angiogenesis models: recent advances and challenges	44
Radiomics MRI for lymph node status prediction in breast cancer patients: the state of art	42
Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells	41
Targeting tumor vascularization: promising strategies for vascular normalization	39
GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients	38
CD36: an emerging therapeutic target for cancer and its molecular mechanisms	38
A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression	38
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials	37
High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD)	35
Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies	34
The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review	34
Large language models for oncological applications	33
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives	32

Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT	32
Cancer immune escape: the role of antigen presentation machinery	31
Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing	31
Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: a randomized clinical trial	31
Inflammatory markers in autoimmunity induced by checkpoint inhibitors	31
MAPK signaling pathway-targeted marine compounds in cancer therapy	30
Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observati	30
The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy	30